Nanjing MeiRui Pharma Co. Ltd
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nanjing MeiRui Pharma Co. Ltd
Deal Watch: Bristol Shores Up Cancer, NASH Pipelines With International Deals
Partnership with France’s Enterome will add a microbiome aspect to Bristol’s immuno-oncology efforts, while its license of Japanese firm Nitto Denko’s siRNA technology could bolster NASH combo therapy development. Meanwhile, Eagle moves into biosimilars with the purchase of Arsia for up to $78m.
- Monitoring Equipment & Devices
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
In Vitro Diagnostics
- Chemistry, Immunoassay
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.